|
Volumn 33, Issue 6, 2015, Pages 654-656
|
Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update 2014
a,b c d b e g h i k l m n j f o p q c r |
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLSALICYLIC ACID;
ANGIOGENESIS INHIBITOR;
ANTICOAGULANT AGENT;
DEXAMETHASONE;
LOW MOLECULAR WEIGHT HEPARIN;
FIBRINOLYTIC AGENT;
ANTICOAGULATION;
ARTICLE;
CLINICAL PRACTICE;
DEEP VEIN THROMBOSIS;
HIGH RISK POPULATION;
HUMAN;
LOW DRUG DOSE;
LUNG EMBOLISM;
MEDICAL SOCIETY;
META ANALYSIS (TOPIC);
MULTIPLE MYELOMA;
NEOPLASM;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
SYSTEMATIC REVIEW (TOPIC);
THROMBOSIS PREVENTION;
TREATMENT INDICATION;
VENOUS THROMBOEMBOLISM;
BLOOD;
ANTICOAGULANTS;
ASPIRIN;
FIBRINOLYTIC AGENTS;
HEPARIN, LOW-MOLECULAR-WEIGHT;
HUMANS;
NEOPLASMS;
VENOUS THROMBOEMBOLISM;
|
EID: 84923167380
PISSN: 0732183X
EISSN: 15277755
Source Type: Journal
DOI: 10.1200/JCO.2014.59.7351 Document Type: Article |
Times cited : (657)
|
References (1)
|